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Abstract: Although membrane environment is known to boost
drug metabolism by mammalian cytochrome P450s, the factors
that stabilize the structural folding and enhance protein
function are unclear. In this study, we use peptide-based lipid
nanodiscs to “trap” the lipid boundaries of microsomal
cytochrome P450 2B4. We report the first evidence that
CYP2B4 is able to induce the formation of raft domains in
a biomimetic compound of the endoplasmic reticulum. NMR
experiments were used to identify and quantitatively determine
the lipids present in nanodiscs. A combination of biophysical
experiments and molecular dynamics simulations revealed
a sphingomyelin binding region in CYP2B4. The protein-
induced lipid raft formation increased the thermal stability of
P450 and dramatically altered ligand binding kinetics of the
hydrophilic ligand BHT. These results unveil membrane/
protein dynamics that contribute to the delicate mechanism
of redox catalysis in lipid membrane.
Structure, function and regulation of membrane proteins are
elicited through interaction with cell membrane.[1] A system-
atic “mapping” of lipid–protein interactions is one of the
current challenges of molecular and cell biology,[1] and could
represent a determinant advancement for understanding
biological processes at membrane level. Indeed, more than
60% of drug targets are located at the cell surface and other
membrane subcellular interfaces.[2] Drugs and xenobiotics
detox functions are also regulated by membrane-anchored
cytochrome P450s[3] located in the cytosolic side of the
endoplasmic reticulum (ER); they have a broad catalytic
activity which includes monooxygenation and dealkylation of
a variety of ligands, including > 70% of commercially
available drugs, as well as xenobiotics;[4] several P450 iso-
forms are also involved in hormone synthesis and the
arachidonic acid cascade.[3] The biophysical challenges
posed by the lipid membrane, as well as its molecular
intricacies, have impeded a molecular characterization of
P450-lipid dynamics. There is consensus about the signifi-
cance of the lipid membrane in the catalytic activity of P450:[5]
it provides the landscape for electron transfer to occur,
through physical interaction with the electron transferase
CPR.[6] Membrane anchoring is one of the speculated
mechanism that prevents P450 trafficking towards other
subcellular compartments.[7] Also, lipid membrane is the main
access pathway for hydrophobic substrates, playing a critical
role in P450 drug metabolism and pharmacokinetics.[8–12]
There is mounting evidence that protein–protein interactions
are also driven by cross-talking between transmembrane
domains (TMD),[13–15] which further amplifies the role of
lipids on the structural stability and function of P450. Thus,
there is a need for new biophysical tools that can enlighten
such presently precluded dynamics, and provide critical
knowledge on the function of P450.
For membrane proteins, the information regarding sub-
cellular organization in different membrane compartments is
obtained through several methods, including indirect deter-
gent-based assay (DRM), single-molecule imaging and spec-
troscopy,[16] and mass spectrometry.[17] Notwithstanding the
critical role of membrane in P450 catalysis, only a few groups
have addressed the fundamental questions regarding the
organization of P450 in ER. DRM experiments reported that
P450 isoforms and CPR likely to co-exist in ER micro-
domains.[18] Nonetheless, given the controversies associated
with DRM,[19] as well as the more recent definition of lipid
rafts as small (< 10 nm) and transient SM-rich domains,[20]
new strategies are needed, particularly to reveal the under-
estimated role played by proteins in driving lipid segregation.
Since P450 strongly interacts with lipid membrane through its
TMD and FG-loop,[15, 21] we hypothesized that any protein-
driven change in lipid composition could be trapped at the
nanometric scale of a nanodisc.
The 4F peptide was able to form nanodiscs (see Figure S1
in the Supporting Information) that retained the ER mem-
brane composition (Table S1) after SEC purification (Fig-
ure S1). Peptide-based nanodiscs have several advantages
over membrane scaffolding protein nanodiscs (MSP) for
studying membrane proteins. First, they allow detergent-free
protein incorporation, which avoids post-reconstitution pu-
rification steps,[22,23] as shown by both size-exclusion chroma-
tography (SEC, Figure S3a) and dynamic light scattering
[*] Dr. C. Barnaba, Dr. B. R. Sahoo, Dr. T. Ravula, Prof. A. Ramamoorthy
Biophysics and Department of Chemistry
University of Michigan
Ann Arbor, MI 48109-1055 (USA)
E-mail: ramamoor@umich.edu
Prof. I. G. Medina-Meza
Department of Biosystems and Agricultural Engineering
Michigan State University
East Lansing, MI 48824-1323 (USA)
Dr. S. Im, Prof. L. Waskell
Department of Anesthesiology
University of Michigan and VA Medical Center
Ann Arbor, MI 48105-1055 (USA)
Prof. G. M. Anantharamaiah
Department of Medicine, UAB Medical Center
Birmingham, Alabama 35294 (USA)
Supporting information and the ORCID identification number(s) for




3449Angew. Chem. 2018, 130, 3449 –3453 T 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
(DLS, Figure S1b and S3b–d). Second, the surrounding
nanodisc belt consists of 4F peptide units (ca. 20 per
nanodisc);[22, 23] compared to MSP nanodiscs, the size of
peptide nanodisc is determined by the lipid:peptide ratio
(Figure S1b). At 1:0.75 w/w lipid:peptide ratio, the diameter
of the nanodisc was 8: 1 nm, which is suitable for P450
monomerization.[23, 24] When incorporated in 4F-nanodiscs,
CYP2B4 showed a predominantly low-spin heme absorption
spectrum (Figure S1d), which is indicative of negligible
interactions between the heme prosthetic group and the
lipid components. Contrary to MSP nanodiscs, peptide-based
nanodiscs allow size-rearrangement and lipid exchange
between nanodiscs.[22] Our approach based on the hypothesis
that the presence of a membrane protein in a fraction of
nanodiscs would perturb the exchange equilibrium in a way
that reflects the ability of the protein itself to recruit or
exclude specific membrane components in its proximate
boundaries.
CYP2B4 was reconstituted in excess 4F-nanodiscs (Fig-
ure 1a), the fraction containing the protein was subsequently
purified by SEC (Figure 1b), and lipids and cholesterol were
quantified (Figure 2a,b). The lipid composition uniquely
reflects the perturbation induced by CYP2B4. The first
observation is that, compared to the initial ER composition
(“ER” in the rest of the manuscript), the lipid profiles were
altered (Figure 2b). Nanodiscs after lipid exchange, (“ERex”)
were enriched of SM (ca. 2.5-fold increase, p< 0.05) and
cholesterol (ca. 1-fold increase, p< 0.001), and with a con-
comitant decrease of zwitterionic PE (ca. 1-fold, p< 0.01).
Cytb5—whose cytosolic domain poorly interact with the
membrane[5]—was used as a control, and as expected it did
not perturb the lipid composition of the nanodiscs (Fig-
ure 2b). Lateral accumulation of saturated SM and choles-
terol is indicative of raft-like liquid-ordered microdomain (lo)
formation.[25] Indeed, protein-induced lipid domains in nano-
discs were corroborated by fluorescence correlation spectros-
copy. For this, we evaluated the partition of the fluorescent
lipid probe DiI C12 into nanodiscs as altered by the presence/
absence of P450 (Figure 2c and Figure S4). When SM-rich
domains were formed, a significant change in the G(0)
autocorrelation function amplitude was observed (Figure 2c
and Table S2), indicating a different distribution of the
fluorescent dye in presence of CYP2B4. Several control
experiments performed on empty nanodiscs, as well as P450-
reconstituted 4F-POPC nanodiscs (Figure S4c) indicated that
DiI C12 was not interacting with protein backbone, or entering
the active site of P450 (Figure S4d), making the heme-
induced fluorescence quenching unlikely.
Next, we investigated if an ordered region surrounding the
protein was important to stability, structure and ligand-
affinity of P450. A first striking evidence of a change in the
membrane organization was the reduction in the nanodiscs
size (ca. 2.2 nm, p< 0.05), likely indicating that the enrich-
ment of SM and cholesterol in CYP2B4 caused the ERex
bilayer to be more tightly “packed” (Figure S5a). CD results
indicated, compared to the protein in solution, no appreciable
changes in the folding (Figure S6a,b). Protein stability to
thermal denaturation is an important parameter for assessing
the effect of membrane on P450.[26] Compared to solution,
CYP2B4 in 4F-ER nanodiscs resulted in an improved thermal
stability with increased Tm (ca. + 4 8C, Figure 2d). The
formation of the lo domain (ERex) further increased Tm (ca.
+ 4 8C), with DH increasing from 118 to 163 kcalmol@1 (p<
0.05). Although a broader profile was observed for ERex, and
could be interpreted in terms of opening of the P450 binding
pocket, additional structural data are needed to confirm this
interpretation; further studies are under progress which will
be published in the future.
In P450, conformational shifts in the protein backbone are
disclosed in the active site environment, by subtle but
observable changes in the heme absorbance spectrum. In
P450, the predominance of low-spin state is due to water as
the sixth ligand,[27, 28] and limiting the access of water to the
active site can lead to high-spin equilibrium shift (Figure S1d
and 2e). These structural and dynamical fluctuations at the
protein/lipid interface can potentially control the opening of
access channels, playing a role in the recruitment of lipophilic
substrates.[29–30] The affinity of P450 for drugs is a critical step
in determining their pharmacokinetics, since the intrinsic
clearance of a pharmacophore is determined by its metabolic
rate and its affinity for the metabolizer.[12, 31] We measured the
spectral binding equilibrium constants (KS) by observing the
ligand-induced spin shift in CYP2B4, when in solution or
Figure 1. Peptide-based nanodiscs as a tool to unveil lipid-boundary
regions of microsomal CYP2B4. a) Schematic of the lipid-exchange
experiment. CYP2B4 was reconstituted with a 2.5-fold excess of empty
nanodiscs and incubated overnight to allow lipid exchange. b) SEC
profiles showing two partially overlapping peaks, representing the
reconstituted and empty fractions, respectively; the protein-containing
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nanodiscs. We compared the effect of ligands, BHTand 4-CPI,
which have different partitioning between membrane and
bulk solution (their logP values are 5.54 and 1.99, respec-
tively). UV/Vis titration with BHT led to several observa-
tions. First, in ERex nanodiscs, the initial high-spin population
([BHT] = 0) was higher than in solution (in ER + 15%, p<
0.05). Second, the equilibrium affinity KS increased by 4-fold
from solution (12 mm) to ERex nanodiscs (3 mm), whereas in
ER it was midway (8 mm). Third, the maximum high-spin
fraction extrapolated by the sigmoidal binding curve showed
a significant increase from solution (40%) to ER (60%);
however, in ERex the lo domain surrounding the protein
increased the population to 100 % high-spin. Similar experi-
ments were performed with the more hydrophilic 4-CPI
(Figure S7), a tight type II binder, which coordinates to the
heme iron through its N-1 atom in the imidazole ring. When in
solution, CYP2B4 showed lower affinity for 4-CPI (KS =
0.2 mm, p< 0.05), with a sigmoidal binding curve indicative
of multiple binding events, as reported.[32] The reconstitution
of CYP2B4 into nanodiscs attenuated the sigmoidal shape of
the binding curve and increased the affinity by 5-fold. No
significant differences were observed in the affinities among
the lipid nature, with the KS values in the 0.04–0.07 mm range
(Figure S7). Hydrophobic ligands, such as BHT, are thought
to partition into the membrane and reach the prosthetic group
towards the 2a channel, situ-
ated between the FG loop
which dips into the lipid mem-
brane. On the other hand,
hydrophilic ligands—such as 4-
CPI—poorly interact with the
membrane layer and are
thought to enter the 2c channel
located between the B’ helix/
BC loop on the protein cyto-
solic domain.
Structural characterization
of membrane proteins in
a closely native lipid environ-
ment is not facile.[33] Alterna-
tively, MD simulation on P450s
embedded in homogeneous
membrane mimetic,[9, 21,34] has
supplied insights into protein/
lipid interfaces, despite not
fully representing the physio-
logical lipids. We performed
both all-atom and coarse-
grained (CG) simulations on
CYP2B4 embedded in POPC,
ER and ERex membranes. The
initial TMD of CYP2B4 was
oriented perpendicular to the
bilayer surface for dynamics
interpretation (Figure 3a).[9]
Under a 100 ns all-atom simu-
lation, CYP2B4 showed no sub-
stantial alteration of protein
folding around the catalytic
site as revealed from its backbone RSMD. The CYP2B4
soluble domain depicted a constrained conformation with an
average RMSD of 2.3 (ER), 2.0 (ERex) and 2.9 c (POPC) in
comparison to its full-length conformation. In contrast, the
RMSD of Ca atoms of the full-length CYP2B4 were higher
than 2.5 c and the average RMSD were 3.1 (ER), 4.2 (ERex)
and 3.6 c (POPC). This suggested that TMD and lipid
composition greatly modulate the overall CYP2B4 dynamics,
and the lipid composition modulates the dynamics of both
TMD and soluble domain.
To gain further insight, we performed CG-MD at micro-
second time scale. As anticipated from the all-atom MD,
a comparatively high TMD dynamics was observed in POPC
(Figure 3b). The perpendicularly oriented TMD-to-bilayer
surface ended with a tilt of ca. 458 during 10 ms MD
simulations for both ER and POPC membrane nanodiscs.
However, the translational motion of TMD (from center) was
much larger in POPC and was restricted by the 4F-peptide
belt. In contrast, the translational motion was well-restrained
in ER membrane nanodiscs during multi-microsecond MD
calculation and was not found in close proximity to the belt
(Figure 3b). Transient interaction between CYP2B4Qs soluble
domain and lipid membrane was consistently observed in all
simulations. Simulations showed that in SM-enriched ER
membrane (ERex), the M1-F20 is an a-helix along the entire
Figure 2. CYP2B4-induced liquid-ordered domain modulates drug affinity. a) 31P NMR on detergent-
treated nanodiscs was used to assess the composition of the protein-containing fraction after overnight
lipid exchange. b) Lipids and cholesterol contents in empty, CYP2B4, and cytb5 4F-ER nanodiscs after
lipid exchange, as measured by 31P NMR and GC-MS. Data are expressed as average:standard deviation
(n = 3). *p<0.05, **p<0.01, ***p<0.001. c) Fluorescence autocorrelation functions for nanodiscs.
Scatter plot represent average : standard deviation of two independent experiments; solid lines
represent numerical fitting using a 3D correlation diffusion model. The lipid probe DiI C12 differently
partitioned in P450-containing nanodiscs, causing changes in the autocorrelation function. d) DSC
curves. e) Protein-induced changes in lipid boundaries alter the affinity for BHT. f) Schematic of lipid-
induced modulation of ligand affinity for BHT.
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course of simulation, whereas in both POPC and ER the M1-
L5 residues were mostly disordered (Figure 3c). Monitoring
the RMS fluctuation of backbone atoms of CYP2B4 in POPC,
ER and ERex membranes (Figure 3d), it was found that
RMS> 2.0 c were observed for TMD, whereas the mobility
of the proline-rich (P36-P49) loop was significant only in
POPC. Loops connecting helix motifs in the soluble domain
showed similar fluctuations over time. In the ER membrane,
the FG-loop (bearing the F’ and G’ helices), as well as b2, b5
and b6 sheets (also known as b-finger) close to the C-terminus
presented higher rigidity, due to an increased interaction with
the membrane hydrophobic core (Figure 3d).
All-atom MD simulations unveiled interactions between
specific residues and lipids (Figure 3). In ER, the soluble
domain was found to interact with lipid head groups, in
particular the FG-loops and the b-finger loop (Figure 3e).
Results also showed SM clustering around the TMD-con-
necting loop and the b-finger, corresponding to the region
spanning the T375 to I382 chain. Further structure analysis
showed H-bonding interaction between SM and Y380 (Fig-
ure 3e, insert). Simulations on ERex showed a dramatic
increase of SM clustering, with additional specific interactions
with the Pro-rich TM connecting loop (G28-L40). The TM a-
helical character of the domain was calculated over the 100-ns
simulation time (Figure S8). Compared to ER, the enrich-
ment of SM and cholesterol in ERex caused the helix to have
an ideal angle (1008) along the entire simulation time
(Figure S8a). Finally, we calculated the number of H-bonds
over simulations in both ER systems, as a tool to evaluate the
interaction with polar groups of the lipids (Figure S8b). As
expected, the number of H-bonds was found to be substan-
tially higher in SM-enriched ERex, indicating more interaction
with the membrane surface. Sequence alignment shows that
both TMD connecting region and b-finger are largely
conserved among microsomal P450s (Figure S9). Particularly,
the b-finger has several conserved hydrophobic residues,
including the 382Ile-Pro-Lys384 sequence, as well as the proline-
rich connector domain. This leads us to hypothesize that other
microsomal P450s can possess similar ability of specific
interaction with lipid components.
In conclusion, this study reveals that P450s is highly
dynamic, and able to interact and modify its surrounding lipid
environment to enhance both function and stability. Protein-
induced formation of SM-rich domain could facilitate P450
monomerization and stability. Recent experimental and
computational evidences on the lateral organization of
microsomal cytochrome P450 pointed to a strong interaction
of both TMD and soluble domain with the lipid
bilayer.[13, 15, 21, 29,33] The results presented here also provide
significant molecular insights into the factors governing P450
ligand affinity for hydrophobic molecules. Further, the
innovative combination of peptide-based nanodiscs and
31P NMR experiments to quantitatively determine the differ-
ent type of lipids constituting nanodiscs will be useful to study
a variety of membrane proteins (like GPCR and pore-
forming proteins[35]) and membrane-assisted amyloid aggre-
gation.
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